Autism spectrum disorder care explained

Autism spectrum disorder (ASD) is a developmental condition involving differences in social communication, restricted interests, repetitive behaviours, and often differences in sensory processing. ASD is a spectrum: presentations range widely, from people who function independently with strengths in particular areas to people who need substantial support throughout life. ASD is identified in roughly 1 in 36 children in the US, with similar identification rates in other countries.

The diagnostic pathway. ASD diagnosis combines structured developmental screening, comprehensive evaluation by a clinician with expertise (developmental paediatrics, child psychiatry, child psychology, often working in teams), and consideration of the full clinical picture. Earlier identification allows earlier intervention, which is associated with better outcomes for many children. Adult-onset diagnosis is also increasingly recognised, particularly for people whose presentations were missed in childhood.

The care approach is multidisciplinary.

Behavioural and educational therapy: applied behaviour analysis (ABA) is the most evidence-based behavioural intervention, particularly when started in early childhood. Approaches and intensity vary; modern ABA emphasises naturalistic, child-centred approaches over older intensive programs that have been criticised. Speech and language therapy, occupational therapy, social skills training, and structured educational support are also core. Family support and parent training are integral; parents and caregivers are essential members of the care team.

Pharmacotherapy. Medications do not treat the core features of ASD itself but are sometimes used for associated symptoms.

For irritability and aggression: risperidone and aripiprazole are approved for ASD-associated irritability and aggression. They can be helpful when behaviour interferes substantially with daily functioning and when behavioural intervention alone is insufficient. Side effects (weight gain, metabolic effects, sedation) are taken seriously and balanced against benefit.

For ADHD-like symptoms: stimulants and non-stimulant ADHD medicines are used in selected patients.

For anxiety and depression: standard antidepressant medicines (SSRIs and others) are used when these comorbidities are present, which is common.

For sleep: melatonin is widely used for sleep-onset issues, which are common in ASD.

The research direction. Mechanism-targeted programs for ASD core symptoms are in late-stage trials. The pathways being targeted include vasopressin signalling (which influences social behaviour), oxytocin signalling, GABA signalling, AMPA receptor modulation, and others. The trials test whether targeted intervention can produce meaningful change in core ASD features, an area where pharmacotherapy has not previously had approved options.

What to expect. Modern ASD care is structured around individualised support that meets each person where they are. The combination of evidence-based behavioural therapy, appropriate educational support, family support, and (where indicated) pharmacotherapy for associated symptoms is the standard. Access to comprehensive specialty care is uneven, and disparities are substantial; advocacy for better access remains an active area of work for families and care providers.